Skip to main content
Top
Published in: Virchows Archiv 6/2012

01-12-2012 | Original Article

The presence of sinusoidal CD163+ macrophages in lymph nodes is associated with favorable nodal status in patients with breast cancer

Authors: Aaron S. Mansfield, Paivi Heikkila, Karl von Smitten, Jukka Vakkila, Marjut Leidenius

Published in: Virchows Archiv | Issue 6/2012

Login to get access

Abstract

As macrophages are some of the first cells to encounter metastatic tumor cells in sentinel lymph nodes (SLN) and natural killer (NK) cells are critical to the cytotoxicity of abnormal cells, we sought to determine if these cell populations were altered in the presence of nodal metastasis. We used immunohistochemistry to assess the SLN of 47 patients with breast cancer (36 with nodal metastasis and 11 without nodal metastasis) and 10 control lymph nodes. We assessed metastatic areas and nonmetastatic areas separately for CD163, a marker of macrophages, and ANK-1, a marker for precursors of activated NK cells. Positively stained cells were manually counted in multiple high-power fields and averaged. Groups were compared with the Kruskal–Wallis test. Spearman rank order test was used for correlations. There was a lower frequency of CD163+ macrophages in the SLN of patients with breast cancer (median, 11.0 %; range, 4.1–20.4 %) than controls (median, 16.5 %; range, 8.9–19.6 %; p = 0.002). There were no differences in the expression of ANK between patients with cancer (median, 1.4 %; range, 0.23–6.3 %) and controls (median, 1.5 %; range, 0.60–5.4 %; p = 0.5). In patients with nodal metastasis, the accumulation of CD163+ cells in the sinuses correlated negatively with CD8+ tumor-infiltrating lymphocytes (r 2 = 0.23; p = 0.001). These results suggest that the reduction of CD163+ macrophages in the sinuses of the SLN is associated with nodal metastasis and may have a role in regional immunity.
Literature
1.
go back to reference Mansfield AS, Heikkila PS, Vaara AT, von Smitten KA, Vakkila JM, Leidenius MH (2009) Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. BMC Cancer 9:231PubMedCrossRef Mansfield AS, Heikkila PS, Vaara AT, von Smitten KA, Vakkila JM, Leidenius MH (2009) Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. BMC Cancer 9:231PubMedCrossRef
2.
go back to reference Mansfield AS, Heikkila P, von Smitten K, Vakkila J, Leidenius M (2011) Metastasis to sentinel lymph nodes in breast cancer is associated with maturation arrest of dendritic cells and poor co-localization of dendritic cells and CD8(+) T cells. Virchows Arch 459:391–398PubMedCrossRef Mansfield AS, Heikkila P, von Smitten K, Vakkila J, Leidenius M (2011) Metastasis to sentinel lymph nodes in breast cancer is associated with maturation arrest of dendritic cells and poor co-localization of dendritic cells and CD8(+) T cells. Virchows Arch 459:391–398PubMedCrossRef
3.
go back to reference Matsuura K, Yamaguchi Y, Osaki A, Ohara M, Okita R, Emi A, Murakami S, Arihiro K (2009) FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients. Oncol Rep 22:1181–1187PubMedCrossRef Matsuura K, Yamaguchi Y, Osaki A, Ohara M, Okita R, Emi A, Murakami S, Arihiro K (2009) FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients. Oncol Rep 22:1181–1187PubMedCrossRef
4.
go back to reference Matsuura K, Yamaguchi Y, Ueno H, Osaki A, Arihiro K, Toge T (2006) Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma. Cancer 106:1227–1236PubMedCrossRef Matsuura K, Yamaguchi Y, Ueno H, Osaki A, Arihiro K, Toge T (2006) Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma. Cancer 106:1227–1236PubMedCrossRef
5.
go back to reference Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee PP (2005) Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med 2:e284PubMedCrossRef Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee PP (2005) Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med 2:e284PubMedCrossRef
6.
go back to reference Angel CE, Chen CJ, Horlacher OC, Winkler S, John T, Browning J, MacGregor D, Cebon J, Dunbar PR (2009) Distinctive localization of antigen-presenting cells in human lymph nodes. Blood 113:1257–1267PubMedCrossRef Angel CE, Chen CJ, Horlacher OC, Winkler S, John T, Browning J, MacGregor D, Cebon J, Dunbar PR (2009) Distinctive localization of antigen-presenting cells in human lymph nodes. Blood 113:1257–1267PubMedCrossRef
7.
go back to reference Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572PubMedCrossRef Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572PubMedCrossRef
8.
9.
10.
go back to reference Sun JC, Beilke JN, Lanier LL (2009) Adaptive immune features of natural killer cells. Nature 457:557–561PubMedCrossRef Sun JC, Beilke JN, Lanier LL (2009) Adaptive immune features of natural killer cells. Nature 457:557–561PubMedCrossRef
11.
go back to reference Li S, Xu J, Makarenkova VP, Tjandrawan T, Vakkila J, Reichert T, Gooding W, Lagenaur CF, Achim CL, Chambers WH, Herberman RB, Whiteside TL, Vujanovic NL (2004) A novel epitope of N-CAM defines precursors of human adherent NK cells. J Leukoc Biol 76:1187–1199PubMedCrossRef Li S, Xu J, Makarenkova VP, Tjandrawan T, Vakkila J, Reichert T, Gooding W, Lagenaur CF, Achim CL, Chambers WH, Herberman RB, Whiteside TL, Vujanovic NL (2004) A novel epitope of N-CAM defines precursors of human adherent NK cells. J Leukoc Biol 76:1187–1199PubMedCrossRef
12.
go back to reference Mansour EG, Ravdin PM, Dressler L (1994) Prognostic factors in early breast carcinoma. Cancer 74:381–400PubMedCrossRef Mansour EG, Ravdin PM, Dressler L (1994) Prognostic factors in early breast carcinoma. Cancer 74:381–400PubMedCrossRef
13.
go back to reference Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP (1980) Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45:2917–2924PubMedCrossRef Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP (1980) Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45:2917–2924PubMedCrossRef
14.
go back to reference Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 7:1239–1251PubMed Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 7:1239–1251PubMed
15.
go back to reference Leidenius MH, Krogerus LA, Toivonen TS, von Smitten KA (2005) Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours. Eur J Surg Oncol 31:364–368PubMedCrossRef Leidenius MH, Krogerus LA, Toivonen TS, von Smitten KA (2005) Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours. Eur J Surg Oncol 31:364–368PubMedCrossRef
16.
go back to reference Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409:198–201PubMedCrossRef Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409:198–201PubMedCrossRef
17.
go back to reference Martens JH, Kzhyshkowska J, Falkowski-Hansen M, Schledzewski K, Gratchev A, Mansmann U, Schmuttermaier C, Dippel E, Koenen W, Riedel F, Sankala M, Tryggvason K, Kobzik L, Moldenhauer G, Arnold B, Goerdt S (2006) Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J Pathol 208:574–589PubMedCrossRef Martens JH, Kzhyshkowska J, Falkowski-Hansen M, Schledzewski K, Gratchev A, Mansmann U, Schmuttermaier C, Dippel E, Koenen W, Riedel F, Sankala M, Tryggvason K, Kobzik L, Moldenhauer G, Arnold B, Goerdt S (2006) Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J Pathol 208:574–589PubMedCrossRef
18.
go back to reference Leidenius MH, Vironen JH, Heikkila PS, Joensuu H (2010) Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer. Ann Surg Oncol 17:254–262PubMedCrossRef Leidenius MH, Vironen JH, Heikkila PS, Joensuu H (2010) Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer. Ann Surg Oncol 17:254–262PubMedCrossRef
19.
go back to reference Leidenius MH, Krogerus LA, Toivonen TS, Von Smitten KJ (2003) The feasibility of intraoperative diagnosis of sentinel lymph node metastases in breast cancer. J Surg Oncol 84:68–73PubMedCrossRef Leidenius MH, Krogerus LA, Toivonen TS, Von Smitten KJ (2003) The feasibility of intraoperative diagnosis of sentinel lymph node metastases in breast cancer. J Surg Oncol 84:68–73PubMedCrossRef
20.
go back to reference Leikola JP, Toivonen TS, Krogerus LA, von Smitten KA, Leidenius MH (2005) Rapid immunohistochemistry enhances the intraoperative diagnosis of sentinel lymph node metastases in invasive lobular breast carcinoma. Cancer 104:14–19PubMedCrossRef Leikola JP, Toivonen TS, Krogerus LA, von Smitten KA, Leidenius MH (2005) Rapid immunohistochemistry enhances the intraoperative diagnosis of sentinel lymph node metastases in invasive lobular breast carcinoma. Cancer 104:14–19PubMedCrossRef
21.
go back to reference Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717–727PubMedCrossRef Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717–727PubMedCrossRef
23.
go back to reference Mantovani A, Marchesi F, Porta C, Sica A, Allavena P (2007) Inflammation and cancer: breast cancer as a prototype. Breast 16(Suppl 2):S27–S33PubMedCrossRef Mantovani A, Marchesi F, Porta C, Sica A, Allavena P (2007) Inflammation and cancer: breast cancer as a prototype. Breast 16(Suppl 2):S27–S33PubMedCrossRef
24.
go back to reference Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14:425–431PubMed Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14:425–431PubMed
25.
go back to reference Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW (2011) The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 105:93–103PubMedCrossRef Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW (2011) The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 105:93–103PubMedCrossRef
26.
go back to reference Mihm MC Jr, Clemente CG, Cascinelli N (1996) Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Invest 74:43–47PubMed Mihm MC Jr, Clemente CG, Cascinelli N (1996) Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Invest 74:43–47PubMed
27.
go back to reference Dewan MZ, Takada M, Terunuma H, Deng X, Ahmed S, Yamamoto N, Toi M (2009) Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients. Biomed Pharmacother 63:703–706PubMedCrossRef Dewan MZ, Takada M, Terunuma H, Deng X, Ahmed S, Yamamoto N, Toi M (2009) Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients. Biomed Pharmacother 63:703–706PubMedCrossRef
Metadata
Title
The presence of sinusoidal CD163+ macrophages in lymph nodes is associated with favorable nodal status in patients with breast cancer
Authors
Aaron S. Mansfield
Paivi Heikkila
Karl von Smitten
Jukka Vakkila
Marjut Leidenius
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 6/2012
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-012-1338-4

Other articles of this Issue 6/2012

Virchows Archiv 6/2012 Go to the issue